ACT rebounds with human embryonic stem cell tech (Mass High Tech: The Journal of New England Technology)
December 16th, 2009
Advanced Cell Technology Inc. last month filed an FDA application to use human embryonic stem cells to treat an untreatable disease that is the most common cause of juvenile blindness. But a little more than a year earlier, the Worcester company was teetering on the brink of extinction.
Original post by macular degeneration – Google News
(click on the author/publication link above to see full post)